- Adefovir dipivoxil for the treatment of lamivudine resistant hepatitis B mutants
-
Hwang SK
- KMID: 2083066
- Korean J Hepatol.
- 2000 Dec;6(4):533-534.
No abstract availalbe. -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine and interferon combination therapy in chronic type B hepatitis
-
Kim YH
- KMID: 1984888
- Korean J Med.
- 2004 Feb;66(2):105-107.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine and interferon combination therapy in chronic type B hepatitis
-
Cho SW
- KMID: 2252670
- Korean J Med.
- 2004 Jan;66(1):1-3.
No abstract availalbe. -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine and interferon combination therapy in chronic type B hepatitis
-
Cho SW
- KMID: 2306021
- Korean J Med.
- 2003 Dec;65(6):629-630.
No abstract availalbe. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
-
Moon JY, Lee SH
- KMID: 2432930
- Korean J Intern Med.
- 2012 Dec;27(4):394-396.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine therapy for type B chronic hepatitis in Korea
-
Lee CH
- KMID: 2251310
- Korean J Med.
- 2000 Apr;58(4):374-377.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Which Method Is Appropriate in Defining the Responsiveness to Lamivudine?
-
Lee HC, Suh DJ
- KMID: 2241258
- Korean J Hepatol.
- 2001 Mar;7(1):1-5.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine: fading into the mists of time
-
Choi J, Lim YS
- KMID: 2406039
- Clin Mol Hepatol.
- 2017 Dec;23(4):314-315.
- doi: 10.3350/cmh.2017.0110
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Lamivudine in Korean Patients with Chronic Hepatitis B
-
Choi JY
- KMID: 760576
- Korean J Hepatol.
- 2005 Mar;11(1):25-30.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine Rescue from the Accelerating Course of Chronic Hepatitis B
-
Joo KR, Song BC, Park MI, Chung YH, Lee YS, Suh DJ
- KMID: 1857616
- Korean J Gastroenterol.
- 2000 Jun;35(6):806-814.
Acute aggravation of chronic hepatitis B is life-threatening, but there has been no acceptable treatment modality except for liver transplantation. Here, we report the effectiveness and safety of lamivudine in... -
- CITED
-
- Close
- SHARE
-
- Close
- Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
-
Nam JY, Lee JH
- KMID: 2406038
- Clin Mol Hepatol.
- 2017 Dec;23(4):311-313.
- doi: 10.3350/cmh.2017.0069
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The management and treatment of chronic hepatitis B in Korean children
-
Choe BH
- KMID: 2140810
- Korean J Pediatr.
- 2007 Sep;50(9):823-834.
- doi: 10.3345/kjp.2007.50.9.823
Interferon (IFN) alpha has been the first line therapy of chronic hepatitis B in children, but HBeAg seroconversion occurred in 26% of treated children compared to 11% of controls in... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Long-erm Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus
-
Kim JS, Han KH, Chung HY, Ahn SH, Paik YH, Lee KS, Chon CY, Moon YM
- KMID: 2241321
- Korean J Hepatol.
- 1999 Jun;5(2):97-104.
BACKGROUND/AIMS: We studied to evaluate the virological and biochemical responses to lamivudine and to detect YMDD mutants in patients who received long-erm lamivudine therapy. METHODS: We conducted a one-ear trial of lamivudine... -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine and adefovir combination therapy in lamivudine-resistant HBeAg-positive chronic hepatitis B patients
-
Lee HC
- KMID: 2305780
- Korean J Med.
- 2009 Dec;77(6):713-715.
The introduction of lamivudine (LAM) has opened a new era for the treatment of chronic hepatitis B (CHB). However, the major drawback of LAM, which currently limits its use as... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevention by Lamivudine of Hepatocellular Carcinoma in Patients Infected with Hepatitis B Virus
-
Lee HJ, Eun R, Jang BI, Kim TN
- KMID: 2167169
- Gut Liver.
- 2007 Dec;1(2):151-158.
BACKGROUND/AIMS: This study evaluated the prevention by lamivudine of hepatocellular carcinoma (HCC) in chronic hepatitis B patients. METHODS: Lamivudine therapy was administered to 879 of the 2,511 patients who satisfied... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of Response to Lamivudine Treatment in Children with Chronic Hepatitis B
-
Kim JS, Park SK, Jeong JY
- KMID: 1973389
- Chonnam Med J.
- 2008 Apr;44(1):37-42.
- doi: 10.4068/cmj.2008.44.1.37
Lamivudine, an oral nucleoside analogue, is a potent inhibitor of hepatitis B virus (HBV) replication. The decision to initiate therapy should be based on variables which are predictive of lamivudine-induced... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
-
Kim HY
- KMID: 2412089
- Gut Liver.
- 2016 Nov;10(6):869-870.
- doi: 10.5009/gnl16476
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus Infection
-
Park NH, Joo KR, Kim DH
- KMID: 2241267
- Korean J Hepatol.
- 2001 Mar;7(1):77-89.
BACKGROUND/AIMS: Lamivudine, an oral nucleoside analogue, effectively suppresses HBV replication and improves liver enzymes as well as liver histology. Long-term lamivudine therapy can induce the emergence of drug resistant HBV... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Experience with Long-term Lamivudine Therapy toDetermine the Adequate Duration of Treatment in Childrenand Adolescents with HBeAg-Negative Chronic Hepatitis B
-
Kim JM, Hong SJ, Choi BH, Chu MA, Cho SM, Choe BH
- KMID: 2037370
- Korean J Pediatr Gastroenterol Nutr.
- 2009 Mar;12(1):23-29.
PURPOSE: To provide the primary data for reaching a consensus on the adequate duration of treatment of lamivudine in children with HBeAg negative chronic hepatitis B. METHODS: Seven of 83 children/adolescents... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Lamivudine in HBV-positive Patients with Progressively Aggravating Chronic Liver Disease and Active HBV DNA Multiplication
-
Lee HJ
- KMID: 2241302
- Korean J Hepatol.
- 2000 Mar;6(1):73-81.
BACKGROUND/AIM: Lamivudine, a reverse-transcriptase inhibitor interferes with viral replication and can reduce the level of infection, thus diminishing an attack by the immune system. The study was conducted to determine... -
- CITED
-
- Close
- SHARE
-
- Close
